{"id":511996,"date":"2021-07-12T16:08:47","date_gmt":"2021-07-12T20:08:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/"},"modified":"2021-07-12T16:08:47","modified_gmt":"2021-07-12T20:08:47","slug":"adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/","title":{"rendered":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SEATTLE, July  12, 2021  (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT) \u00a0a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p align=\"justify\">Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gzfoujZxwaZXLmitpFsroOBfMiifkCNrj9IgjuBbsRgo1UahDd_cG2MCVvOyWIzsrN03hJosH58OrJyvOMMcOlBW23BaMvzQCcKCDpXchtw=\" rel=\"nofollow noopener\" target=\"_blank\">www.adaptivebiotech.com<\/a>. The webcast will be archived and available for replay within 24 hours after the event.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Adaptive Biotechnologies<br \/><\/strong>Adaptive Biotechnologies\u00a0is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature\u2019s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics and drug discovery. We have three commercial products and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.<\/p>\n<p>\n        <strong>ADAPTIVE INVESTORS<\/strong><br \/>\n        <br \/>Karina Calzadilla, Vice President, Investor Relations<br \/>201-396-1687<br \/>Carrie Mendivil,\u00a0Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=INBP5ZwzcK_FQBl5r2sj6Z-FQ0o1chY3zNCp_3RinstiBEqF-zlmly3Kp_oZ24OF0gwKgsw5f3-cfnRld6zvFJm2Ekm4iAame2BwXMqto0BMETCQYpxsylG2ueJBfe1P\" rel=\"nofollow noopener\" target=\"_blank\">investors@adaptivebiotech.com<\/a><\/p>\n<p>\n        <strong>ADAPTIVE MEDIA<\/strong><br \/>\n        <br \/>Beth Keshishian<br \/>917-912-7195<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ung3PzIAlpSgD_hNO2KPqZ9kZqIq5mBZ78Ysc-S1vZBtXz5NjbMRTsdX6uTP5o0qRxqb1S0AJDgT_6tyHwO_P0E_c8Gl45hGxZ3HAGnfqD4=\" rel=\"nofollow noopener\" target=\"_blank\">media@adaptivebiotech.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c51e4b61-9911-4bb5-a30d-f62f8ba297a8\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT) \u00a0a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About\u00a0Adaptive BiotechnologiesAdaptive Biotechnologies\u00a0is a commercial-stage biotechnology company focused on harnessing the inherent &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511996","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT) \u00a0a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About\u00a0Adaptive BiotechnologiesAdaptive Biotechnologies\u00a0is a commercial-stage biotechnology company focused on harnessing the inherent &hellip; Continue reading &quot;Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T20:08:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021\",\"datePublished\":\"2021-07-12T20:08:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/\",\"name\":\"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\",\"datePublished\":\"2021-07-12T20:08:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/","og_locale":"en_US","og_type":"article","og_title":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk","og_description":"SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT) \u00a0a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About\u00a0Adaptive BiotechnologiesAdaptive Biotechnologies\u00a0is a commercial-stage biotechnology company focused on harnessing the inherent &hellip; Continue reading \"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-12T20:08:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021","datePublished":"2021-07-12T20:08:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/","name":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=","datePublished":"2021-07-12T20:08:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODk3OCM0MjkzMTcxIzIxNzcxODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511996"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}